<?xml version='1.0' encoding='utf-8'?>
<document id="24699894"><sentence text="Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects."><entity charOffset="43-55" id="DDI-PubMed.24699894.s1.e0" text="oxyhydroxide" /><entity charOffset="60-68" id="DDI-PubMed.24699894.s1.e1" text="losartan" /><entity charOffset="70-80" id="DDI-PubMed.24699894.s1.e2" text="furosemide" /><entity charOffset="82-92" id="DDI-PubMed.24699894.s1.e3" text="omeprazole" /><entity charOffset="94-101" id="DDI-PubMed.24699894.s1.e4" text="digoxin" /><entity charOffset="106-114" id="DDI-PubMed.24699894.s1.e5" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e0" e2="DDI-PubMed.24699894.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e0" e2="DDI-PubMed.24699894.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e0" e2="DDI-PubMed.24699894.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e0" e2="DDI-PubMed.24699894.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e0" e2="DDI-PubMed.24699894.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e0" e2="DDI-PubMed.24699894.s1.e5" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e1" e2="DDI-PubMed.24699894.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e1" e2="DDI-PubMed.24699894.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e1" e2="DDI-PubMed.24699894.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e1" e2="DDI-PubMed.24699894.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e1" e2="DDI-PubMed.24699894.s1.e5" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e2" e2="DDI-PubMed.24699894.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e2" e2="DDI-PubMed.24699894.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e2" e2="DDI-PubMed.24699894.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e2" e2="DDI-PubMed.24699894.s1.e5" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e3" e2="DDI-PubMed.24699894.s1.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e3" e2="DDI-PubMed.24699894.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e3" e2="DDI-PubMed.24699894.s1.e5" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e4" e2="DDI-PubMed.24699894.s1.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s1.e4" e2="DDI-PubMed.24699894.s1.e5" /></sentence><sentence text="The novel iron-based phosphate binder sucroferric oxyhydroxide is being investigated for the treatment of hyperphosphatemia"><entity charOffset="10-14" id="DDI-PubMed.24699894.s2.e0" text="iron" /><entity charOffset="21-30" id="DDI-PubMed.24699894.s2.e1" text="phosphate" /><pair ddi="false" e1="DDI-PubMed.24699894.s2.e0" e2="DDI-PubMed.24699894.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24699894.s2.e0" e2="DDI-PubMed.24699894.s2.e1" /></sentence><sentence text=" Patients with chronic kidney disease often have multiple comorbidities that may necessitate the daily use of several types of medication" /><sentence text=" Therefore, the potential pharmacokinetic drug-drug interactions between sucroferric oxyhydroxide and selected drugs commonly taken by dialysis patients were investigated" /><sentence text="" /><sentence text="Five Phase I, single-center, open-label, randomized, three-period crossover studies in healthy volunteers investigated the effect of a single dose of sucroferric oxyhydroxide 1 g (based on iron content) on the pharmacokinetics of losartan 100 mg, furosemide 40 mg, omeprazole 40 mg, digoxin 0"><entity charOffset="189-193" id="DDI-PubMed.24699894.s6.e0" text="iron" /><entity charOffset="230-238" id="DDI-PubMed.24699894.s6.e1" text="losartan" /><entity charOffset="247-257" id="DDI-PubMed.24699894.s6.e2" text="furosemide" /><entity charOffset="265-275" id="DDI-PubMed.24699894.s6.e3" text="omeprazole" /><entity charOffset="283-290" id="DDI-PubMed.24699894.s6.e4" text="digoxin" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e0" e2="DDI-PubMed.24699894.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e0" e2="DDI-PubMed.24699894.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e0" e2="DDI-PubMed.24699894.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e0" e2="DDI-PubMed.24699894.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e0" e2="DDI-PubMed.24699894.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e1" e2="DDI-PubMed.24699894.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e1" e2="DDI-PubMed.24699894.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e1" e2="DDI-PubMed.24699894.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e1" e2="DDI-PubMed.24699894.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e2" e2="DDI-PubMed.24699894.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e2" e2="DDI-PubMed.24699894.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e2" e2="DDI-PubMed.24699894.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e3" e2="DDI-PubMed.24699894.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s6.e3" e2="DDI-PubMed.24699894.s6.e4" /></sentence><sentence text="5 mg and warfarin 10 mg" /><sentence text=" Pharmacokinetic parameters [including area under the plasma concentration-time curve (AUC) from time 0 extrapolated to infinite time (AUC0-∞) and from 0 to 24 h (AUC0-24)] for these drugs were determined: alone in the presence of food; with sucroferric oxyhydroxide in the presence of food; 2 h after food and sucroferric oxyhydroxide administration" /><sentence text="" /><sentence text="Systemic exposure based on AUC0-∞ for all drugs, and AUC0-24 for all drugs except omeprazole (for which AUC 0-8 h was measured), was unaffected to a clinically significant extent by the presence of sucroferric oxyhydroxide, irrespective of whether sucroferric oxyhydroxide was administered with the drug or 2 h earlier"><entity charOffset="82-92" id="DDI-PubMed.24699894.s10.e0" text="omeprazole" /><entity charOffset="198-222" id="DDI-PubMed.24699894.s10.e1" text="sucroferric oxyhydroxide" /><pair ddi="false" e1="DDI-PubMed.24699894.s10.e0" e2="DDI-PubMed.24699894.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24699894.s10.e0" e2="DDI-PubMed.24699894.s10.e1" /></sentence><sentence text="" /><sentence text="There is a low risk of drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, digoxin and warfarin"><entity charOffset="66-78" id="DDI-PubMed.24699894.s12.e0" text="oxyhydroxide" /><entity charOffset="83-91" id="DDI-PubMed.24699894.s12.e1" text="losartan" /><entity charOffset="93-103" id="DDI-PubMed.24699894.s12.e2" text="furosemide" /><entity charOffset="105-112" id="DDI-PubMed.24699894.s12.e3" text="digoxin" /><entity charOffset="117-125" id="DDI-PubMed.24699894.s12.e4" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e0" e2="DDI-PubMed.24699894.s12.e0" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e0" e2="DDI-PubMed.24699894.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e0" e2="DDI-PubMed.24699894.s12.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e0" e2="DDI-PubMed.24699894.s12.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e0" e2="DDI-PubMed.24699894.s12.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e1" e2="DDI-PubMed.24699894.s12.e1" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e1" e2="DDI-PubMed.24699894.s12.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e1" e2="DDI-PubMed.24699894.s12.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e1" e2="DDI-PubMed.24699894.s12.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e2" e2="DDI-PubMed.24699894.s12.e2" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e2" e2="DDI-PubMed.24699894.s12.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e2" e2="DDI-PubMed.24699894.s12.e4" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e3" e2="DDI-PubMed.24699894.s12.e3" /><pair ddi="false" e1="DDI-PubMed.24699894.s12.e3" e2="DDI-PubMed.24699894.s12.e4" /></sentence><sentence text=" There is also a low risk of drug-drug interaction with omeprazole (based on AUC0-∞ values)"><entity charOffset="56-66" id="DDI-PubMed.24699894.s13.e0" text="omeprazole" /></sentence><sentence text=" Therefore, sucroferric oxyhydroxide may be administered concomitantly without the need to adjust the dosage regimens of these drugs" /><sentence text="" /></document>